170 related articles for article (PubMed ID: 36836438)
1. Barriers and Facilitators to the Implementation of Personalised Medicine across Europe.
Stefanicka-Wojtas D; Kurpas D
J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836438
[TBL] [Abstract][Full Text] [Related]
2. eHealth and mHealth in Chronic Diseases-Identification of Barriers, Existing Solutions, and Promoters Based on a Survey of EU Stakeholders Involved in Regions4PerMed (H2020).
Stefanicka-Wojtas D; Kurpas D
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330466
[TBL] [Abstract][Full Text] [Related]
3. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe.
Horgan D; Jansen M; Leyens L; Lal JA; Sudbrak R; Hackenitz E; Bußhoff U; Ballensiefen W; Brand A
Public Health Genomics; 2014; 17(5-6):287-98. PubMed ID: 25401385
[TBL] [Abstract][Full Text] [Related]
4. Personalised Medicine-Implementation to the Healthcare System in Europe (Focus Group Discussions).
Stefanicka-Wojtas D; Kurpas D
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983562
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Facilitators and barriers for home-based monitoring to time frozen embryo transfers in IVF among women and healthcare providers.
Zaat TR; de Bruin JP; Mol F; van Wely M
Hum Reprod Open; 2022; 2022(3):hoac021. PubMed ID: 35702341
[TBL] [Abstract][Full Text] [Related]
7. Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals' education and citizens' empowerment in personalised medicine.
Beccia F; Causio FA; Hoxhaj I; Huang HY; Wang L; Wang W; Farina S; Osti T; Savoia C; Cadeddu C; Ricciardi W; Boccia S
BMC Med Educ; 2023 Jun; 23(1):438. PubMed ID: 37316817
[TBL] [Abstract][Full Text] [Related]
8. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
9. A survey of experts on personalized medicine landscape in European Union and China.
Hoxhaj I; Beccia F; Morsella A; Cadeddu C; Ricciardi W; Boccia S
BMC Health Serv Res; 2023 May; 23(1):517. PubMed ID: 37221524
[TBL] [Abstract][Full Text] [Related]
10. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
[TBL] [Abstract][Full Text] [Related]
11. Stakeholders barriers and facilitators for the implementation of a personalised digital care pathway: a qualitative study.
Heijsters F; Santema J; Mullender M; Bouman MB; Bruijne M; van Nassau F
BMJ Open; 2022 Nov; 12(11):e065778. PubMed ID: 36418140
[TBL] [Abstract][Full Text] [Related]
12. Appetite for change? Facilitators and barriers to nutrition guideline implementation in Canadian recreational facilities.
Kirk SFL; Olstad DL; McIsaac JD; Prowse RJL; Caswell S; Hanning R; Raine KD; Mâsse LC; Naylor PJ
Health Promot Int; 2021 Dec; 36(6):1672-1682. PubMed ID: 33615376
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Barriers and facilitators to dissemination and adoption of precision medicine among Hispanics/Latinos.
Canedo JR; Wilkins CH; Senft N; Romero A; Bonnet K; Schlundt D
BMC Public Health; 2020 May; 20(1):603. PubMed ID: 32357943
[TBL] [Abstract][Full Text] [Related]
15. Capitalizing on facilitators and addressing barriers when implementing active tuberculosis case-finding in six districts of Ho Chi Minh City, Vietnam: a qualitative study with key stakeholders.
Biermann O; Tran PB; Forse RJ; Vo LNQ; Codlin AJ; Viney K; Caws M; Lönnroth K
Implement Sci; 2021 May; 16(1):54. PubMed ID: 34011353
[TBL] [Abstract][Full Text] [Related]
16. Building on facilitators and overcoming barriers to implement active tuberculosis case-finding in Nepal, experiences of community health workers and people with tuberculosis.
Biermann O; Dixit K; Rai B; Caws M; Lönnroth K; Viney K
BMC Health Serv Res; 2021 Apr; 21(1):295. PubMed ID: 33794878
[TBL] [Abstract][Full Text] [Related]
17. Barriers and Facilitators Affecting Patient Portal Implementation from an Organizational Perspective: Qualitative Study.
Kooij L; Groen WG; van Harten WH
J Med Internet Res; 2018 May; 20(5):e183. PubMed ID: 29752253
[TBL] [Abstract][Full Text] [Related]
18. Active and healthy ageing in urban environments: laying the groundwork for solution-building through citizen science.
Wood GER; Pykett J; Stathi A
Health Promot Int; 2022 Aug; 37(4):. PubMed ID: 36102480
[TBL] [Abstract][Full Text] [Related]
19. The Roadmap toward Personalized Medicine: Challenges and Opportunities.
Cinti C; Trivella MG; Joulie M; Ayoub H; Frenzel M;
J Pers Med; 2024 May; 14(6):. PubMed ID: 38929767
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators to kangaroo mother care implementation in Cote d'Ivoire: a qualitative study.
Kourouma KR; Agbré-Yacé ML; Doukouré D; Cissé L; Some-Méazieu C; Ouattara J; Tano-Kamelan A; Konan Kouakou V
BMC Health Serv Res; 2021 Nov; 21(1):1211. PubMed ID: 34753464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
